Package 85534-0006-9

{"route": ["ORAL"], "spl_id": "3745abec-26fc-d50e-e063-6294a90a037d", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["b4a1d3b8-afcf-47e3-96d3-469d8f408a31"], "manufacturer_name": ["HAWAII REPACK, INC."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-1)", "package_ndc": "85534-0006-1", "marketing_start_date": "20250611"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-3)", "package_ndc": "85534-0006-3", "marketing_start_date": "20250611"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-5)", "package_ndc": "85534-0006-5", "marketing_start_date": "20250611"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-6)", "package_ndc": "85534-0006-6", "marketing_start_date": "20250611"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-9)", "package_ndc": "85534-0006-9", "marketing_start_date": "20250611"}], "brand_name": "Bupropion Hydrochloride", "product_id": "85534-0006_3745abec-26fc-d50e-e063-6294a90a037d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "85534-0006", "generic_name": "Bupropion Hydrochloride", "labeler_name": "HAWAII REPACK, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077285", "marketing_category": "ANDA", "marketing_start_date": "20150217", "listing_expiration_date": "20261231"}